All News

The Hematology/Oncology Pharmacy Association (HOPA) created committees, inclusion statements, and diversity, equity, and inclusion (DEI) checkpoints to improve healthcare for underserved or historically less included populations.

Before tapering patients treated for cancer off of opioids, care providers should first establish what the goals of tapering are.

The data underscore the need for biomarker testing to identify patients who may be eligible for this therapy, according to physician from Memorial Sloan Kettering Cancer Center.

Pharmacists respond to questions about supplementation and and smoking cessation for heart health.

Pharmacists respond to questions about birth control.

Certain populations have been found to have differing prognoses, such as African American patients, who have an earlier onset of disease with a higher likelihood of an aggressive tumor type and shorter survival.

Asian Americans often develop the disease at a normal weight, which would be overlooked by current screening guidelines, investigators say.

The drug from AstraZeneca and Ionis Pharmaceuticals demonstrates a sustained benefit through 66 weeks for those with hereditary transthyretin-mediated amyloid polyneuropathy.

Experts note that pharmacists are well positioned to play a key role in precision oncology and molecular tumor boards.

Legal expert breaks down the history of power between federal v. state law and why Dobbs v. Jackson has caused such a stir for the pharmaceutical community.

Historically, there are many hard-to-treat mutations of non-small cell lung cancer.

The company announced the initiation of the EVERGREEN study, which was aimed to evaluate the efficacy, safety, and immunogenicity of the investigational respiratory syncytial virus vaccine, in 2021.

Products include an as needed treatment for bronchoconstriction and a treatment for Alzheimer disease.

Pharmacists need food too, you know.

This month's guest is Jennifer Lind, PharmD, MPH, MBA, a public health pharmacists, epidemiologist in the Medication Safety Program at the CDC, and commander in the United States Public Health Service Commissioned Corps.

Barbara Kirkaldy, BS, CPhT, pharmacy regulatory specialist at Novant Health, discusses her role in the pharmacy and alternative career paths for pharmacy technicians.

Authorized for use in professional point-of-care settings, the nucleic acid amplification diagnostic tool delivers results in 25 minutes.

Regeneron and Sanofi’s Dupilumab is the first biologic to demonstrate a clinically meaningful and statistically significant reduction in exacerbations compared with the placebo.

The implementation of genetic testing for patients prescribed medications associated with progressive multifocal leukoencephalopathy is likely to improve safety outcomes.

Studies show that patients who are introduced to patient support programs through digital platforms are more likely to use support services.

Quantitative polymerase chain reaction methods that are validated to determine bacterial load are important for assessing the impact of vaccines in public health programs.

Products include multivitamin gummies and a superfood supplement.

Eflapegrastim-xnst subcutaneous injection (Rolvedon) reduces infections related to febrile neutropenia in adults with nonmyeloid malignant tumors who are being treated with certain anticancer drugs.

President (2022 to 2023) of the Hematology Oncology Pharmacists Association (HOPA) highlights the many ways that hematology/oncology pharmacists can collaborate with care teams to improve access to care at HOPA Annual Conference 2023 in Phoenix, Arizona from March 29 to April 1.

FDA action allows for OTC naloxone (Narcan) to be sold directly to consumers in pharmacies, convenience stores, grocery stores, gas stations, and online.

Follow Pharmacy Times®’ live coverage of the Hematology/Oncology Pharmacy Association (HOPA) Annual Conference in Phoenix, Arizona from March 29 to April 1, 2023.

The main cause of C. diff infection remains antibiotic use and overuse.

Improvements in progression-free survival were seen in patients with advanced or recurrent endometrial carcinoma regardless of mismatch repair status.